Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Food and Drug Administration FDA Approves New Medication for Chronic Weight Management (Zepbound / tirzepatide)
Synergy with Dermal Rolling Dermal rolling (microneedling) creates microchannels that significantly improve topical peptide absorption
Our 3% formulation uses a phospholipid-based delivery system designed to protect the GHK-Cu complex during transit through the lipid-rich outer skin layers and release it at the dermal-epidermal junction
Verified Buyer Rated 5 out of 5 based on 1 customer rating One of my favorite compounds to research
When to seek medical attention Seek immediate medical care for: Any signs of severe allergic reaction Fever with injection site infection signs Chest pain or significant cardiovascular symptoms Severe or persistent neurological symptoms Any symptom that feels like a medical emergency Seek prompt (but not emergency) medical attention for: Symptoms that persist beyond two weeks without improvement Symptoms that progressively worsen rather than improve New symptoms that appear after initial adjustment period Any symptom that significantly impairs daily function Do not let concern about discussing peptide use prevent you from seeking appropriate care
